Investigating secondary hyperhidrosis.
نویسندگان
چکیده
ing hormone and follicle stimulating hormone with a low oestradiol concentration confirm menopausal status. In peri menopause, some menstrual bleeding may still be occurring, and luteinising hormone, follicle stimulating hormone and oestradiol may be normal, or only follicle stimulating hor mone may be raised. If there is any doubt about perimeno pausal status, blood tests should be repeated in the first few days after the onset of menstrual bleeding, when follicle stimulating hormone is likely to be raised. Thyroid function is an important investigation as hyperthy roidism can lead to sweating and to menstrual irregularities with oligomenorrhoea. This should be evident with a low con centration of thyroid stimulating hormone in the context of a raised free thyroxine (fT4) or free triiodothyronine (fT3). Full blood count should be done to look for any underlying haematological disorder, in particular a lymphoproliferative or myeloproliferative disorder. Lymphoma is the most com mon malignancy associated with night sweats, with around 25% of patients with Hodgkin’s disease experiencing low RATIONAL TESTING Investigating secondary hyperhidrosis
منابع مشابه
The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
BACKGROUND Hyperhidrosis (primary or secondary) is excessive sweating beyond that required to return body temperature to normal. It can be localized or generalized, commonly affecting the axillae, palms, soles or face, and can have a substantial negative effect on a patient's quality of life. IMPACT OF DISEASE Objective evaluation comprising quantitative assessment (gravimetric and Minor's io...
متن کاملIncidence and prevalence of hyperhidrosis.
Hyperhidrosis is a skin disorder characterized by excessive sweating that often causes significant impairment in social, occupational, and emotional wellbeing. Hyperhidrosis is thought to affect 2.8% of the US population and can be of primary or secondary origin. Primary hyperhidrosis is usually bilateral, symmetric, and focal. The most common focal sites include, but are not limited to, the pa...
متن کاملFamilial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment
TNF: tumor necrosis factor INTRODUCTION Hyperhidrosis is a disorder caused by overactivity of the eccrine glands and characterized by excessive sweating beyond what is essential for thermoregulation. Its prevalence is 3% in the US population and affects men and women equally. Hyperhidrosis can be classified as either primary, which tends to be focal, or secondary, which tends to be more general...
متن کاملGlycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
Hyperhidrosis, or abnormally increased sweating, is a condition that may have a primary or secondary cause. Usually medication- induced secondary hyperhidrosis manifests with generalized, rather than focal sweating. We report a 32-year-old woman with a history of palmoplantar hyperhidrosis for 15 years who presented for treatment and was prescribed oral glycopyrrolate. One month later, the palm...
متن کاملImpact of hyperhidrosis on quality of life and its assessment.
Hyperhidrosis is an embarrassing condition that may interfere with routine activities, cause emotional distress, and disturb both professional and social lives of patients. Objective examination is variable and unreliable, so efforts have been made in the last 15 years to substantiate the limitations of these patients, especially in primary focal hyperhidrosis. Almost all therapeutic studies us...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 341 شماره
صفحات -
تاریخ انتشار 2010